Tjeerd Barf
Oprichter bij Acerta Pharma BV
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Roger Ulrich | M | - |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 11 jaar |
| Ad W. van Gorp | M | - |
Cytura Therapeutics BV
 Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | 5 jaar |
| Allard Kaptein | M | - |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 12 jaar |
| Arwin Ridder | M | - |
Artica Therapeutics BV
 Artica Therapeutics BV Pharmaceuticals: MajorHealth Technology Artica Therapeutics BV develops covalent therapeutics for autoimmune and inflammatory disorders. The company is based in Leiden, Netherlands. The Dutch company was founded in 2020 by Ad IJzerman, Arwin Ridder, Tjeerd Barf. Tjeerd Barf has been the CEO since 2020. | 4 jaar |
| Ad IJzerman | M | - |
Artica Therapeutics BV
Artica Therapeutics BV Pharmaceuticals: MajorHealth Technology Artica Therapeutics BV develops covalent therapeutics for autoimmune and inflammatory disorders. The company is based in Leiden, Netherlands. The Dutch company was founded in 2020 by Ad IJzerman, Arwin Ridder, Tjeerd Barf. Tjeerd Barf has been the CEO since 2020. | 4 jaar |
| Marc Dunoyer | M | 71 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | - |
| Harrold van Barlingen | M | 58 |
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | - |
| Pascal Soriot | M | 64 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | - |
| Patrick Chaltin | M | - |
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Nederland | 9 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Tjeerd Barf
- Persoonlijk netwerk